Patient preferences for stratified medicine in psoriasis: a discrete choice experiment*-Reference-Cited by-同舟云学术

Patient preferences for stratified medicine in psoriasis: a discrete choice experiment*

Published:2021-07-29 Issue:5 Volume:185 Page:978-987
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Dalal G.¹^ORCID,Wright S.J.¹,Vass C.M.¹²,Davison N.J.¹³,Vander Stichele G.⁴,Smith C.H.⁵,Griffiths C.E.M.⁶^ORCID,Payne K.¹^ORCID,

Affiliation:

1. Manchester Centre for Health Economics The University of Manchester Manchester M13 9PL UK

2. RTI Health Solutions Manchester M20 2LS UK

3. BresMed Health Solutions Manchester M1 4BT UK

4. Mindbytes Ghent Belgium

5. St John’s Institute of Dermatology Guy’s and St. Thomas’ NHS Foundation Trust and Kings College London London UK

6. The Dermatology Centre Salford Royal NHS Foundation Trust The University of Manchester NIHR Manchester Biomedical Research Centre Manchester UK

Funder

Riksbankens Jubileumsfond

Medical Research Council

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.20482

Reference45 articles.

1. National Institute for Health and Care Excellence (NICE).Psoriasis: assessment and management. Available athttps://www.nice.org.uk/guidance/cg153/resources/psoriasis‐assessment‐and‐management‐pdf‐35109629621701(last accessed 15 June 2021).

2. Adverse events resulting in withdrawal of biologic therapy for psoriasis in real-world clinical practice: A Canadian multicenter retrospective study

3. Risk of Serious Infection in Patients with Psoriasis Receiving Biologic Therapies: A Prospective Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

4. Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis

5. HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pet Owners’ Preferences for Quality of Life Improvements and Costs Related to Innovative Therapies in Feline Pain Associated with Osteoarthritis—A Quantitative Survey;Animals;2024-08-08

2. Dog Owners’ Perceptions of the Convenience and Value of Chewable Oclacitinib: Quantitative Survey Data from an International Survey;Animals;2024-03-19

3. Risk of respiratory tract infections and serious infections in psoriasis patients treated with biologics: Results from the BioCAPTURE registry;JEADV Clinical Practice;2022-06-24

4. Economics and Precision Medicine;Handbook of Experimental Pharmacology;2022

5. Stratified psoriasis treatment plans: why is patient preference information needed?;British Journal of Dermatology;2021-08-31